Blog
Illuminating Cancer Cells To Help Guide Surgery
BlogSurgery, when used as a cancer treatment, is a procedure in which a surgeon identifies and removes the cancerous tissue from a patient’s body. To ensure the cancer doesn’t return it is critical that the surgeon is able to remove all of the cancer. We recently spoke with Christopher Barys, Chief Executive Officer at On Target Laboratories to learn more about the novel cancer imaging agents they are currently developing and to discover how they can be used to help surgeons identify and resect cancerous lesions.
Read More
Fighting Neurodegeneration by Understanding Inflammation
BlogNeurodegenerative diseases are one of the most pressing challenges of our time and teasing out the cellular mechanisms underpinning these diseases is a key goal for researchers in the field. We talked to Stéphane Martinez of CISBIO to discuss how researchers can access information on neurodegenerative mechanisms and how we are beginning to recognize the contribution of the immune system to neurodegeneration.
Read More
Method “Matches” Medicines to Their Unique Protein Receptors
BlogA receptor (drug target) can shift from a single subunit to a multi-structure in the presence of a ligand (drug compound) – a process known as "oligomerization". Now, using photon excitation microscopy, researchers report that they can uncover the various protein receptor oligomers formed in the absence or presence of different drug candidates that bind to them.
Read More
A Conversation on the "Latest and Greatest" in Metabolomics
BlogAided by advances in high-throughput technologies, the metabolomics research field has gained significant traction. We spoke with Baljit Ubhi, Ph.D. from SCIEX, about the recent developments in metabolomics, addressing the increasing focus on the microbiome, how it impacts metabolic disease, and the future directions of research, including "precision nutrition".
Read More
Life Science Technology Megatrends Shaping Our Future
BlogMegatrends are overarching trends, ones that seed and embrace multiple market and technology developments. These trends already exist in our world today but are going to be even more important in the years to come. Here we highlight three technology megatrends that could be highly significant to our future.
Read More
Applying Precision Genomics in Biopharma Drug Development
BlogA recent collaboration between Onconova Therapeutics and Mission will utilize the Mission Bio TapestriⓇ Platform to conduct targeted single-cell DNA analysis for the study of Onconova's novel cancer therapy, Rigosertib. We spoke with Darrin Crisitello, CCO of Mission Bio, to learn more.
One-by-One and All-at-Once: The Future of Cellular Phenotypic Screening
BlogAs scientists, we’re often subjected to certain stereotypes. We’re assumed to be smart and nerdy; we work long hours, wear lab coats, and obsess over data. Some or all of these traits and behaviors may ring true at a population level, but for individual scientists they don’t always stack up. The same disconnect applies to cells. We assume that the average phenotype is representative of all of the members of a population, but too often it is not...
Read More
First-of-Its-Kind Lipidomics Excellence Award Acknowledges Forward-thinking in a Rapidly Growing Field
BlogTechnology Networks recently visited Dresden, Germany, for Lipotype's Lipid Excellence Award press talk, where we gained insights into the past, present and future of lipidomics research.
Read More
Measuring Millions of Protein–Protein Interactions Simultaneously
BlogWe recently had the pleasure of speaking with David Younger, PhD., Co-founder and CEO of A-Alpha Bio, to learn more about AlphaSeq – a platform designed to measure millions of protein–protein interactions simultaneously.
Read More
Cell Conversions Transformed From Black Box Guesswork to Systematic Discovery
BlogPredicting the reprogramming factors necessary to induce cell conversion has largely relied on trial and error, revealing the need for a more systematic approach.
To learn more about Mogrify's approach to achieving cell conversion through transdifferentiation, we interviewed Pierre-Louis Joffrin, Corporate Development Executive at Mogrify.
